AZD2389
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for AZD2389, covering 2025-04-29 to 2026-07-06. Get the full timeline:
Most recent: Clinical Trial Results: A Study to Evaluate the Safety, Tolerability, PK, and PD Effects of AZD2389 in Participants With Liver Fibrosis and Compensated Cirrhosis. [Phase 2]